BRPI0717737A2 - Métodos para desativar vírus, reduzir o risco de infecção viral e/ou tratar enfermidades virais em um mamífero, reduzir a inflamação e risco de inflamação em um mamífero, higienizar a pele de mamíferos, manufaturar um esfregão, tratar uma superfície visada e manufaturar uma toalha de secagem antimicrobiana - Google Patents

Métodos para desativar vírus, reduzir o risco de infecção viral e/ou tratar enfermidades virais em um mamífero, reduzir a inflamação e risco de inflamação em um mamífero, higienizar a pele de mamíferos, manufaturar um esfregão, tratar uma superfície visada e manufaturar uma toalha de secagem antimicrobiana

Info

Publication number
BRPI0717737A2
BRPI0717737A2 BRPI0717737-2A2A BRPI0717737A BRPI0717737A2 BR PI0717737 A2 BRPI0717737 A2 BR PI0717737A2 BR PI0717737 A BRPI0717737 A BR PI0717737A BR PI0717737 A2 BRPI0717737 A2 BR PI0717737A2
Authority
BR
Brazil
Prior art keywords
risk
reduce
murifurs
manufursar
hygienize
Prior art date
Application number
BRPI0717737-2A2A
Other languages
English (en)
Inventor
Michael Lynch
Rudyard Istvan
Original Assignee
Michael Lynch
Rudyard Istvan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Lynch, Rudyard Istvan filed Critical Michael Lynch
Publication of BRPI0717737A2 publication Critical patent/BRPI0717737A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
BRPI0717737-2A2A 2006-10-10 2007-10-09 Métodos para desativar vírus, reduzir o risco de infecção viral e/ou tratar enfermidades virais em um mamífero, reduzir a inflamação e risco de inflamação em um mamífero, higienizar a pele de mamíferos, manufaturar um esfregão, tratar uma superfície visada e manufaturar uma toalha de secagem antimicrobiana BRPI0717737A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85102806P 2006-10-10 2006-10-10
PCT/US2007/080788 WO2008045860A2 (en) 2006-10-10 2007-10-09 Methods of inactivating viruses

Publications (1)

Publication Number Publication Date
BRPI0717737A2 true BRPI0717737A2 (pt) 2013-10-22

Family

ID=39283568

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0717737-2A2A BRPI0717737A2 (pt) 2006-10-10 2007-10-09 Métodos para desativar vírus, reduzir o risco de infecção viral e/ou tratar enfermidades virais em um mamífero, reduzir a inflamação e risco de inflamação em um mamífero, higienizar a pele de mamíferos, manufaturar um esfregão, tratar uma superfície visada e manufaturar uma toalha de secagem antimicrobiana

Country Status (9)

Country Link
US (1) US20090035339A1 (pt)
EP (1) EP2091528A4 (pt)
JP (1) JP2010505964A (pt)
CN (1) CN101563077A (pt)
BR (1) BRPI0717737A2 (pt)
CA (1) CA2666146A1 (pt)
IL (1) IL198087A0 (pt)
MX (1) MX2009003766A (pt)
WO (1) WO2008045860A2 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090062391A1 (en) * 2007-08-27 2009-03-05 Kent Christopher New Use of a virucidal ointment in the nares for prevention of transmission and contraction of common colds
US20090263439A1 (en) * 2008-04-18 2009-10-22 The Procter & Gamble Company Antimicrobial Preservative Free Wipe
JP5126745B2 (ja) * 2008-07-22 2013-01-23 国立大学法人鳥取大学 抗ウイルス剤及び抗ウイルス性シート
JP5255495B2 (ja) * 2009-03-19 2013-08-07 ディバーシー株式会社 殺カリシウイルス剤組成物およびその使用方法
PT3425035T (pt) 2009-05-12 2021-10-22 Ecolab Usa Inc Auxiliar de enxaguamento de secagem rápida e drenagem rápida
JP5513610B2 (ja) * 2009-05-28 2014-06-04 エコラボ ユーエスエー インコーポレイティド 無菌充填用の湿潤剤
WO2011011567A1 (en) * 2009-07-22 2011-01-27 Sentinel Products Corp. Antimicrobial composition containing parachlormetaxylenol
US9744125B2 (en) * 2010-01-15 2017-08-29 Nuance Health, Llc Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses
PE20131103A1 (es) * 2010-08-27 2013-09-23 Anitox Corp Formula antimicrobiana
WO2013054197A1 (en) * 2011-10-13 2013-04-18 Amril Ag A potentiator for soluble liquid herbicide
US9567551B2 (en) 2012-06-22 2017-02-14 Ecolab Usa Inc. Solid rinse aid composition and method of making same
US9011610B2 (en) 2012-06-22 2015-04-21 Ecolab Usa Inc. Solid fast draining/drying rinse aid for high total dissolved solid water conditions
US9808435B2 (en) * 2013-03-12 2017-11-07 Ecolab Usa Inc. Antiviral compositions and methods for inactivating non-enveloped viruses using alkyl 2-hydroxycarboxylic acids
US9393252B2 (en) 2013-03-12 2016-07-19 Ecolab Usa Inc. Aromatic carboxylic acids in combination with aromatic hydroxyamides for inactivating non-enveloped viruses
JP6246512B2 (ja) * 2013-07-12 2017-12-13 ロンシール工業株式会社 抗ウイルス性壁紙
JP6341358B2 (ja) * 2013-07-12 2018-06-13 ロンシール工業株式会社 抗ウイルス性ポリ塩化ビニル系樹脂組成物及び抗ウイルス性ポリ塩化ビニル系樹脂成形体
EP3020761B1 (en) 2013-07-12 2021-12-22 Lonseal Corporation Antiviral vinyl chloride resin composition, antiviral vinyl chloride resin sheet, and method for manufacturing same, interior sheet, method for manufacturing interior sheet, polyvinyl chloride resin interior sheet, antiviral wallpaper, and method for manufacturing antiviral wallpaper
JP2015030947A (ja) * 2013-08-05 2015-02-16 ロンシール工業株式会社 抗ウイルス性壁紙
FR3019714B1 (fr) * 2014-04-10 2017-07-07 Salveco Nouveaux produits biocides
JP6867743B2 (ja) * 2014-11-27 2021-05-12 ロンシール工業株式会社 抗ウイルス性を有する表面処理剤及び表面処理剤が塗布されている抗ウイルス性シート状物
JP6837732B2 (ja) * 2015-01-09 2021-03-03 ロンシール工業株式会社 抗ウイルス性成形材料及びその製造方法
US9982220B2 (en) 2015-05-19 2018-05-29 Ecolab Usa Inc. Efficient surfactant system on plastic and all types of ware
EP3464541B1 (en) 2016-05-23 2020-04-29 Ecolab USA Inc. Reduced misting alkaline and neutral cleaning, sanitizing, and disinfecting compositions via the use of high molecular weight water-in-oil emulsion polymers
CA3025298C (en) 2016-05-23 2021-04-20 Ecolab Usa Inc. Reduced misting acidic cleaning, sanitizing, and disinfecting compositions via the use of high molecular weight water-in-oil emulsion polymers
US11540512B2 (en) 2017-03-01 2023-01-03 Ecolab Usa Inc. Reduced inhalation hazard sanitizers and disinfectants via high molecular weight polymers
WO2019067560A1 (en) 2017-09-26 2019-04-04 Ecolab Usa Inc. ANTIMICROBIAL COMPOSITIONS AND ACID / ANIONIC VIROCIDES AND USES THEREOF
CA3107070A1 (en) 2018-07-25 2020-01-30 Ecolab Usa Inc. Rinse aid formulation for cleaning automotive parts
WO2020022441A1 (ja) * 2018-07-27 2020-01-30 富士フイルム株式会社 抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー、化合物
JP2022540474A (ja) 2019-07-12 2022-09-15 エコラボ ユーエスエー インコーポレイティド アルカリ可溶性エマルジョンポリマーの使用によりミストが低減したアルカリ性洗浄剤
JP7421902B2 (ja) 2019-10-25 2024-01-25 花王株式会社 ウイルス不活性化剤組成物
JP7421904B2 (ja) 2019-10-25 2024-01-25 花王株式会社 ウイルス不活性化剤組成物
CA3161330A1 (en) * 2019-12-16 2021-06-24 Ecolab Usa Inc. Anionic surfactant impact on virucidal efficacy
JP7406679B2 (ja) * 2021-03-12 2023-12-28 積水化学工業株式会社 ウイルス感染阻止剤及びウイルス感染阻止製品
WO2024034649A1 (ja) * 2022-08-10 2024-02-15 積水化学工業株式会社 ウイルス感染阻止剤、樹脂組成物及びウイルス感染阻止製品
WO2024043320A1 (ja) * 2022-08-26 2024-02-29 積水化学工業株式会社 ウイルス感染阻止剤、ウイルス感染阻止製品及びウイルス感染阻止製品の製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975217A (en) * 1981-07-20 1990-12-04 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
DK315482A (da) * 1981-07-20 1983-01-21 Kimberly Clark Co Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden
DE3622089A1 (de) * 1986-07-02 1988-01-07 Krueger Gmbh & Co Kg Viruzides mittel mit breitbandwirkung
DE4140473C2 (de) * 1991-12-09 1995-12-21 Schuelke & Mayr Gmbh Hautantiseptikum und Händedesinfektionsmittel
GB2309706B (en) * 1996-01-31 2000-02-09 Reckitt & Colman Inc Liquid detergent composition comprising quaternary ammonium surfactant having germicidal properties
EP1248830A1 (en) * 2000-01-20 2002-10-16 The Procter & Gamble Company Antimicrobial compositions
US20020192407A1 (en) * 2001-03-01 2002-12-19 The Procter & Gamble Company Pre-moistened wipe with improved feel and softness
FR2822377A1 (fr) * 2001-03-23 2002-09-27 Oreal Utilisation de fibres comme agent anti-irritant dans une composition cosmetique ou dermatologique
US6846846B2 (en) * 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
US20040001797A1 (en) * 2002-06-21 2004-01-01 Abel Saud Antimicrobial compositions, products and methods employing same
US20050271711A1 (en) * 2004-04-26 2005-12-08 The Procter & Gamble Company Therapeutic antimicrobial compositions and methods
MX2007006862A (es) * 2004-12-09 2008-02-15 Dial Corp Composiciones que tienen alta eficacia antiviral y antibacterial.
RU2008151178A (ru) * 2006-05-24 2010-06-27 Дзе Дайл Корпорейшн (Us) Способы и изделия, обладающие сильным противовирусным и противобактериальным действием

Also Published As

Publication number Publication date
CN101563077A (zh) 2009-10-21
MX2009003766A (es) 2009-07-10
EP2091528A2 (en) 2009-08-26
WO2008045860A3 (en) 2008-11-13
US20090035339A1 (en) 2009-02-05
WO2008045860A2 (en) 2008-04-17
CA2666146A1 (en) 2008-04-17
JP2010505964A (ja) 2010-02-25
EP2091528A4 (en) 2010-07-14
IL198087A0 (en) 2009-12-24

Similar Documents

Publication Publication Date Title
BRPI0717737A2 (pt) Métodos para desativar vírus, reduzir o risco de infecção viral e/ou tratar enfermidades virais em um mamífero, reduzir a inflamação e risco de inflamação em um mamífero, higienizar a pele de mamíferos, manufaturar um esfregão, tratar uma superfície visada e manufaturar uma toalha de secagem antimicrobiana
HK1253532A1 (zh) 用於治療變應性、炎性和感染性疾病的嘌呤衍生物
BR112012008048A2 (pt) dispositivos eletrocrômicos, montagens que incorporam dispositivos eletrocrômicos, e/ou métodos de fabricação dos mesmos
BRPI0820183A2 (pt) Prevenção e tratamento de infecções secundárias após infecção viral
IL212984A (en) Vaccines to treat or reduce the risk of mammalian viral infection containing at least two differentiated optimized HIV-1 viral polypeptides and drugs containing them
DK2197486T3 (da) Mindskelse af ledsagende infektioner i svin ved anvendelse af PCV2-antigen
BR112013014376A2 (pt) materiais em partículas, compósitos compreendendo os mesmos, preparação e usos dos mesmos
BRPI0820578A2 (pt) Vírus da varíola, processo para preparar um vírus da varíola, composição, uso de um vírus da varíola ou de uma composição, e, método para tratar doenças
FI20085515A0 (fi) Menetelmä ja järjestely turvavalaisimen yhteydessä
SMT201500132B (it) Trattamento dell'infezione da virus dell'epatite bda solo o in combinazione con virus dell'epatite delta e delle patologie epatiche associate
BRPI0918353A2 (pt) máscaras faciais em dobras planas e pregueadas
BRPI0808800A2 (pt) elementos de cerâmicas de alta resistência e processo para fabricação e utilização dos mesmos
BR112013012563A2 (pt) bactéria recombinante e processo de elaboração de glicerol
BRPI0911176A2 (pt) Métodos de extinção melhorados para inativação de patógeno de células vermelhas sanguíneas
FI20095001A0 (fi) Järjestelmä ja menelmät kaskoditehovahvistimia varten
ATE515937T1 (de) Mähdrescher mit zusätzlicher leistungsquelle und intelligentem leistungsmanagement
DK1994152T3 (da) Peptider der er effektive i behandlingen af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler
BRPI1016257A2 (pt) composições compreendendo finafloxacino e métodos para tratar infecções oftálmicas, ópticas ou nasais
EE05414B1 (et) Meetod kartuli viirushaigustest tervendamiseks ja parandatud omadustega meristeemkloonide loomiseks, viirusvaba kartuli meristeemtaim ning viirusvaba kartul
BRPI0820019A2 (pt) Modo para melhorar aparência da pele usando partículas macroscópias tratadas
BR112013014189A2 (pt) composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
BRPI0822931A2 (pt) Válvula de gatilho de escapamento monobloco e método de tratamento térmico em solução da mesma
BRPI0716137A2 (pt) Utilização de açúcares de c7 na prevenção e no tratamento de micoses
BRPI1007080A2 (pt) tecidos compostos resistentes a virus e resistentes a sangue
BR112013008078A2 (pt) tratamentos de infecção por vírus da hepatite c

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]